Alison conlin retweetledi

Do pts with small (≤1cm) ER+ tumors with high genomic risk benefit from chemo? Interesting analysis of MINDACT: favorable outcomes (93% 8y DMFS) & no clear benefit from chemo despite high genomic risk. Think twice before giving chemo for T1a/b ER+ tumors. nature.com/articles/s4152…

English


















